BioSpace News Archive

Biomerics LLC is pleased to announce the acquisition of FutureMatrix Interventional, Inc.

At the American Society Clinical Oncology’s 2018 annual meeting, scientists from National Institute of Cancer Research Taiwan reported results from a phase 1 clinical study, showing that Polaris lead therapeutic candidate ADI-PEG 20 in combination with pembrolizumab has activity for advanced solid tumors.

Rebiotix Inc. announced that data analyses from clinical studies of the company’s first two Microbiota Restoration Therapy™ products, RBX7455 and RBX2660, as well as ongoing Microbiome Health Index™ research, will be presented in two podium presentations and one poster presentation during the Digestive Disease Week 2018 (DDW2018) meeting.

Milliman, Inc. announced the availability of its annual research into the financial results and administrative expenses associated with Medicaid managed care plans.

John Greisch Joins Board as MedPlast Continues Global Services Expansion

Harbour BioMed and The Wistar Institute announced that they have entered into a multi-year, multifaceted research collaboration to co-discover novel antibodies for the treatment of cancer and infectious diseases.

Syntimmune, Inc. announced that President and Chief Executive Officer Jean-Paul Kress, M.D., will present at the Jefferies 2018 Global Healthcare Conference.

SCIEX announced a new release of its LC and mass spectrometry operating system, SCIEX OS software.

SCIEX has announced today that it will highlight a suite of recent innovations for streamlining biotherapeutics research and development, as well as its latest technologies for delivering accessible, high performance clinical diagnostics, at ASMS 2018.

Spineology Inc., announces FDA clearance of its Rampart One™ Standard ALIF device allowing it to be used with or without supplemental fixation.